Latest Breaking News On - Research lead for the gynaecology unit - Page 1 : comparemela.com

Verastem Oncology Announces Initiation of a Confirmatory Phase 3 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer

Verastem Oncology Announces Initiation of a Confirmatory Phase 3 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesCity ofSusana banerjeeRyan porterDan patersonRachel grishamElisa buffingtonResearch lead for the gynaecology unitSecura bio incFoundation incEuropean society of gynaecological oncologyCorporate communicationsNational cancer instituteInstitute of cancer researchEuropean network for gynaecological oncological trial

Verastem Oncology (VSTM) Announces Initiation of a Confirmatory Phase 3 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer

Verastem Oncology (VSTM) Announces Initiation of a Confirmatory Phase 3 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomDan patersonRachel grishamSusana banerjeeDrug administrationInstitute of cancer researchFoundation incCompany phaseResearch lead for the gynaecology unitEuropean network of gynaecological oncological trialTeam leader in women cancersVerastem oncologyChief executive officerBreakthrough therapy designationAccelerated approval